Cargando…

Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in Osteosarcoma

BACKGROUND: Survival outcomes for patients with osteosarcoma (OS) have remained stagnant over the past three decades. Insulin-like growth factor 1 receptor (IGF1R) is over-expressed in a number of malignancies, and anti-IGF1R antibodies have and are currently being studied in clinical trials. Unders...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yu, Roth, Michael, Piperdi, Sajida, Montoya, Kristofer, Sowers, Rebecca, Rao, Pulivarthi, Geller, David, Houghton, Peter, Kolb, E. Anders, Gill, Jonathan, Gorlick, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149550/ https://www.ncbi.nlm.nih.gov/pubmed/25170759 http://dx.doi.org/10.1371/journal.pone.0106249

Ejemplares similares

Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model
por: Yang, Yi, et al.
Publicado: (2017)

Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma
por: Poon, Vincent I, et al.
Publicado: (2015)

Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
por: Koirala, Pratistha, et al.
Publicado: (2016)

The effect of bone morphogenetic protein-2 on osteosarcoma metastasis
por: Gill, Jonathan, et al.
Publicado: (2017)

Detection of circulating tumor DNA in patients with osteosarcoma
por: Barris, David M., et al.
Publicado: (2018)

HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival
por: Koirala, Pratistha, et al.
Publicado: (2016)

CD49b inhibits osteogenic differentiation and plays an important role in osteosarcoma progression
por: Ren, Tingting, et al.
Publicado: (2017)

β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells
por: Piperdi, Sajida, et al.
Publicado: (2012)

Variability in the reported management of pulmonary metastases in osteosarcoma
por: Bhattasali, Onita, et al.
Publicado: (2015)

Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors
por: Karkare, Sharayu, et al.
Publicado: (2019)

Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma
por: Zhang, Yidan, et al.
Publicado: (2018)

Endothelial Insulin and IGF-1 Receptors: When Yes Means NO
por: Muniyappa, Ranganath, et al.
Publicado: (2012)

p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma
por: Currier, Arthur W., et al.
Publicado: (2019)

Impairment of Methotrexate Transport Is Common in Osteosarcoma Tumor Samples
por: Sowers, Rebecca, et al.
Publicado: (2011)

A Review of Targeted Therapies Evaluated by the Pediatric Preclinical Testing Program for Osteosarcoma
por: Sampson, Valerie B., et al.
Publicado: (2013)

Insulin/IGF-1R, SIRT1, and FOXOs Pathways—An Intriguing Interaction Platform for Bone and Osteosarcoma
por: Sergi, Consolato, et al.
Publicado: (2019)

Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma
por: Man, Tsz-Kwong, et al.
Publicado: (2004)

A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells
por: Shin, Min Hwa, et al.
Publicado: (2016)

Prognostic and Therapeutic Utility of Variably Expressed Cell Surface Receptors in Osteosarcoma
por: Zvi, Yoav, et al.
Publicado: (2021)

Sensitization and translocation of TRPV1 by insulin and IGF-I
por: Van Buren, Jeremy J, et al.
Publicado: (2005)

Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma
por: Broqueza, Jaline, et al.
Publicado: (2021)

A Fasting Insulin–Raising Allele at IGF1 Locus Is Associated with Circulating Levels of IGF-1 and Insulin Sensitivity
por: Mannino, Gaia Chiara, et al.
Publicado: (2013)

Phase separation of insulin receptor substrate 1 drives the formation of insulin/IGF-1 signalosomes
por: Gao, Xiu Kui, et al.
Publicado: (2022)

Leptocarpin Suppresses Proliferation, Migration, and Invasion of Human Osteosarcoma by Targeting Type-1 Insulin-Like Growth Factor Receptor (IGF-1R)
por: Zheng, Shao-wei, et al.
Publicado: (2017)

Molecular Characterisation of Long-Acting Insulin Analogues in Comparison with Human Insulin, IGF-1 and Insulin X10
por: Hansen, Bo F., et al.
Publicado: (2012)

Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients
por: Molina, Eric R., et al.
Publicado: (2022)

Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin
por: Slaaby, Rita
Publicado: (2015)

Central insulin‐like growth factor‐1 (IGF‐1) restores whole‐body insulin action in a model of age‐related insulin resistance and IGF‐1 decline
por: Huffman, Derek M., et al.
Publicado: (2015)

IGF1 and IGF2 specificities to the two insulin receptor isoforms are determined by insulin receptor amino acid 718
por: Andersen, Mie, et al.
Publicado: (2017)

Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody
por: Kim, Jun Gyu, et al.
Publicado: (2012)

Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls
por: Chang, Hua-Pin, et al.
Publicado: (2018)

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma
por: Wang, Yifei, et al.
Publicado: (2022)

Gengnianchun Extends the Lifespan of Caenorhabditis elegans via the Insulin/IGF-1 Signalling Pathway
por: Meng, Fanhui, et al.
Publicado: (2018)

Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes
por: Ma, Zhulin, et al.
Publicado: (2014)

Insulin growth factor 1 like receptor (IGF-1R)
por: Iyer, Gopal, et al.
Publicado: (2016)

IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
por: Kuijjer, Marieke L, et al.
Publicado: (2013)

MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1
por: Tan, Xinyu, et al.
Publicado: (2015)

Insulin glargine affects the expression of Igf-1r, Insr, and Igf-1 genes in colon and liver of diabetic rats
por: Juárez-Vázquez, Clara I, et al.
Publicado: (2018)

Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection
por: Cohen, Ehud, et al.
Publicado: (2010)

Human insulin/IGF-1 and familial longevity at middle age
por: Rozing, Maarten P., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8tjrqd3nh0m07ftm6pbk53sp6s